Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen
about
Graft rejection - endogenous or allogeneic?Clinical Implications of Basic Science Discoveries: Immune Homeostasis and the Microbiome-Dietary and Therapeutic Modulation and Implications for TransplantationSelective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.Induction of tolerance for islet transplantation for type 1 diabetes.In remembrance of things past: memory T cells and transplant rejection.Heterologous immunity: an overlooked barrier to tolerance.Crossing the bridge: large animal models in translational transplantation research.Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primatesMemory T cells in transplantation: generation, function, and potential role in rejection.Transplantation tolerance in pediatric recipients: lessons and challenges.Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.Homeostatic T cell proliferation as a barrier to T cell tolerance.Transplant tolerance in non-human primates: progress, current challenges and unmet needs.Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.Recent progress in tolerance induction through mixed chimerism.Viral infection: a potent barrier to transplantation tolerance.Transplantation tolerance: lessons from experimental rodent models.Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.An Evaluation of 20 Years of EU Framework Programme-Funded Immune-Mediated Inflammatory Translational Research in Non-Human Primates.Mechanism of cellular rejection in transplantationCross-immune tolerance: conception and its potential significance on transplantation toleranceRecent progress and new perspectives in studying T cell responses to allografts.Transplantation tolerance through mixed chimerism.A more selective costimulatory blockade of the CD28-B7 pathway.Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory.Innate pathways of immune activation in transplantation.HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.Pivotal role of nuclear factor kappaB signaling in anti-CD40-induced liver injury in mice.Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.An antibody combination that targets activated T cells extends graft survival in sensitized recipients.Rat Cytomegalovirus Infection Interferes with Anti-CD4 mAb-(RIB 5/2) Mediated Tolerance and Induces Chronic Allograft DamageDetermining T-cell specificity to understand and treat disease
P2860
Q26866523-297E9095-812E-44AD-912B-BB04B6023615Q28085515-CDD6CF89-413F-4959-93DC-9D02816B999DQ34149246-BF4D11AE-EF05-48E1-BFE8-158A8C7DDFBBQ35179356-5403E624-CE10-4A88-9462-8D81956B4583Q35583502-40AC983C-25AF-4A8A-9247-74FF953AEEDCQ35583521-9E4DF3B6-EF02-4D2A-90C4-4256FE7F7B50Q35583529-6791CEAA-BDF3-4197-8344-BE57FE538EA6Q35680600-04D4847A-8C21-41B0-9961-2D43282731F7Q35775330-43142220-6749-4A55-AA59-4D7CC7B194AAQ36018578-D7E96215-01FE-4624-92CF-7465015EDD22Q36122631-5D9667DF-A288-4896-A5DA-85A175081100Q36251301-2DE6A21E-1525-4284-AEA4-3182CB8E9AD1Q36447590-DF6F3C0C-B67D-463C-B506-2D8F150A18EDQ36528984-B08D7F2D-5169-4C64-83CD-DE15EC6786D0Q36863016-11065EE0-1D1E-4E56-8017-032C2A491FC9Q36876313-FCF5265E-95FA-4329-B99B-83A033C036EFQ36915471-2B8D921B-2C40-4DAF-A7E9-2201D95C14BDQ37060516-B0BD01DC-5578-47B9-BF25-FDE0F8175FC4Q37397401-52AB1512-E463-434A-98B6-90227805F6FAQ37424651-4069696F-8FF9-41BE-AF0E-B6E71FD83529Q37661374-6EDC1A9B-FA69-4E83-A1B2-025F5605E1BDQ37721479-F0520EB7-5A53-41E6-AC7C-1EEC4D5A0C1AQ37784380-50F196DD-A537-4139-91CE-5D1A693420F6Q37801975-1D3E690A-B1F9-489A-96F0-1F60BF15633CQ38187176-876DD66D-583D-4556-A6A0-F6F9AC7776A4Q40380028-147CA483-B019-4FB0-A034-9DF860E14A40Q41874130-B028F0D6-1DF0-4C18-8B6B-7DDEB92836ABQ42210078-64E2BBBB-0BCB-4E2C-8F58-A50D48549D93Q43669186-FDCF620E-56BA-4EFE-8BE9-E402219C5AADQ44917322-4F3FF796-5A6A-4220-8AB4-2223657285C2Q51962057-C1C322EA-AB63-45F0-87DE-48982DFC4D71Q56989355-95ABF2B7-DB4C-484A-A7AD-0581B45437E0Q57201489-45523457-5909-4E57-9433-8F4AA4B62705
P2860
Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen
description
im November 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2002
@uk
name
Cutting Edge: Persistent Viral ...... 28/CD40 Blockade-Based Regimen
@en
Cutting Edge: Persistent Viral ...... 28/CD40 Blockade-Based Regimen
@nl
type
label
Cutting Edge: Persistent Viral ...... 28/CD40 Blockade-Based Regimen
@en
Cutting Edge: Persistent Viral ...... 28/CD40 Blockade-Based Regimen
@nl
prefLabel
Cutting Edge: Persistent Viral ...... 28/CD40 Blockade-Based Regimen
@en
Cutting Edge: Persistent Viral ...... 28/CD40 Blockade-Based Regimen
@nl
P2093
P1476
Cutting edge: persistent viral ...... 28/CD40 blockade-based regimen
@en
P2093
Andrew B Adams
Christian P Larsen
Megan M Durham
Rafi Ahmed
Thandi M Onami
Thomas C Pearson
P304
P356
10.4049/JIMMUNOL.169.10.5387
P407
P577
2002-11-01T00:00:00Z